Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Doug AltmanOn the 3rd June 2018, when Professor Doug Altman passed away, the statistics community lost one of its greatest statisticians. Doug Altman was a Professor of Statistics in Medicine at the University of Oxford. He was an internationally acclaimed statistician, who was best known for improving the quality of medical research. His contribution to the discipline of statistics are profound and have been, and continue to be, of far reaching consequence.

Doug led the Medical Statistics Group of Cancer Research UK from 1988. His immersion in clinical research led to Doug’s popular book “Practical Statistics for Medical Research” which was published in 1991. The group moved from London to Oxford in 1995, where he founded the Centre for Statistics in Medicine (CSM). In 2006 he founded the Equator Network, which seeks to improve the quality of scientific publications by promoting transparent and accurate reporting of health research.

In 2015, Doug was awarded the BMJ Lifetime Achievement Award and was quoted as saying in an article announcing the award that “Perpetually seeing bad articles in medical journals just got to me. I felt aggrieved by it. It was a waste of money, of course, and a breach of ethics, but that only occurred to me later. At the time, it just seemed wrong.”  Doug sought to address these concerns, focussing his career on continuing to develop new methodologies whilst advocating for practical guidelines and transparency. 

CSM continues under the Directorship of Professor Sallie Lamb. Only a few weeks before his death, Doug took both great pride and enjoyment in participating in the annual CSM away day, and celebrating the achievements of junior, mid-career and senior medical statisticians at the University of Oxford.

Similar stories

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.